` OSSR (Ossur hf) vs OMX Copenhagen 25 Comparison - Alpha Spread

OSSR
vs
OMX Copenhagen 25

Over the past 12 months, OSSR has outperformed OMX Copenhagen 25, delivering a return of -10% compared to the OMX Copenhagen 25's 16% drop.

Stocks Performance
OSSR vs OMX Copenhagen 25

Loading
OSSR
OMX Copenhagen 25
Add Stock

Performance Gap
OSSR vs OMX Copenhagen 25

Loading
OSSR
OMX Copenhagen 25
Difference

Performance By Year
OSSR vs OMX Copenhagen 25

Loading
OSSR
OMX Copenhagen 25
Add Stock

Competitors Performance
Ossur hf vs Peers

OMX Copenhagen 25
OSSR
ABT
ISRG
BSX
SYK
Add Stock

Ossur hf
Glance View

Market Cap
11.3B DKK
Industry
Health Care

Össur hf. is an Icelandic company that stands as a quiet marvel in the realm of orthopedic innovation, specializing in the development of non-invasive equipment designed to enhance human mobility. Born out of a small prosthetics shop in Reykjavik in 1971, the company has grown into a global leader in orthopedic solutions. At its core, Össur's operations revolve around the invention and commercialization of cutting-edge prosthetics, braces, and supports aimed at improving the quality of life for people who face limb challenges due to injuries, disabilities, or age-related conditions. The company's ethos of "Life Without Limitations" guides its pursuit to blend medical technology and engineering in a way that restores human dignity and functionality, manifesting a unique synergy between advanced robotics and biology. Commercially, Össur thrives by leveraging its commitment to research and development, channeling substantial investment into creating high-demand products characterized by reliability, adaptability, and innovation. Revenue streams primarily flow from the sale of prosthetic limbs and associated components, together with orthopedic support products that are distributed both directly and through a network of wholesalers and medical professionals worldwide. By maintaining a diversified product line and focusing on customer-centric customization, Össur meets a significant demand within healthcare systems, insurance providers, and direct consumer markets. The company's ability to translate its scientific prowess into marketable and life-enhancing solutions has cemented its reputation as a key player in the med-tech industry, aligning financial success with a meaningful social mission.

OSSR Intrinsic Value
22.74 DKK
Overvaluation 14%
Intrinsic Value
Price
O
Back to Top